| SCHOTT PHARMA INH O.N. |
| Deutschland |
| Industrie |
| DE000A3ENQ51 / A3ENQ5 |
| 1SXP (Frankfurt) |
| FRA:1SXP, ETR:1SXP, 1SXP:GR |
| SDAX |
| https://www.schott.com/ |
|
SCHOTT Pharma AG & Co. KGaA is a leading provider of drug containment and delivery solutions, specializing in primary packaging for injectable pharmaceuticals. Headquartered in Mainz, Germany, and part of SCHOTT AG owned by the Carl Zeiss Foundation,..
>Volltext.. |
| 2625.67 Mio. EUR |
| 2599.77 Mio. EUR |
| 1002.16 Mio. EUR |
| 257.01 Mio. EUR |
| 144.76 Mio. EUR |
| 0.96 EUR |
| - |
| 28.09 Mio. EUR |
| 204.69 Mio. EUR |
| 0.07 |
| 1.98% |
| -2.89% |
| 0.18 EUR |
| 1.03% |
| 1.03% |
| 04.02.26 - 0.18€ 05.02.25 - 0.16€ >weitere anzeigen... |
| - |
| SCHOTT PHARMA |
| 07.07.26 |
|
||||
|
||||
|
||||
|